The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

High Blood Pressure Drugs (Hypertension)-Global Market Insights and Sales Trends 2025

High Blood Pressure Drugs (Hypertension)-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1831553

No of Pages : 107

Synopsis
The global High Blood Pressure Drugs (Hypertension) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of High Blood Pressure Drugs (Hypertension) in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, are propelling High Blood Pressure Drugs (Hypertension) market. ACEI, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CCB segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for High Blood Pressure Drugs (Hypertension), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global High Blood Pressure Drugs (Hypertension) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global High Blood Pressure Drugs (Hypertension) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, High Blood Pressure Drugs (Hypertension) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of High Blood Pressure Drugs (Hypertension) covered in this report include Eli Lilly, Pfizer, Bayer, Symplmed, Novartis, Merck, Sanofi, Boryung and Reata Pharmaceuticals, etc.
The global High Blood Pressure Drugs (Hypertension) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Pfizer
Bayer
Symplmed
Novartis
Merck
Sanofi
Boryung
Reata Pharmaceuticals
Lung Biotechnology
Yuhan
Takeda
Alvogen
Global High Blood Pressure Drugs (Hypertension) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global High Blood Pressure Drugs (Hypertension) market, Segment by Type:
ACEI
CCB
ARB
Global High Blood Pressure Drugs (Hypertension) market, by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of High Blood Pressure Drugs (Hypertension) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of High Blood Pressure Drugs (Hypertension) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 High Blood Pressure Drugs (Hypertension) Market Overview
1.1 High Blood Pressure Drugs (Hypertension) Product Overview
1.2 High Blood Pressure Drugs (Hypertension) Market Segment by Type
1.2.1 ACEI
1.2.2 CCB
1.2.3 ARB
1.3 Global High Blood Pressure Drugs (Hypertension) Market Size by Type
1.3.1 Global High Blood Pressure Drugs (Hypertension) Market Size Overview by Type (2018-2029)
1.3.2 Global High Blood Pressure Drugs (Hypertension) Historic Market Size Review by Type (2018-2023)
1.3.3 Global High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America High Blood Pressure Drugs (Hypertension) Sales Breakdown by Type (2018-2023)
1.4.2 Europe High Blood Pressure Drugs (Hypertension) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America High Blood Pressure Drugs (Hypertension) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales Breakdown by Type (2018-2023)
2 Global High Blood Pressure Drugs (Hypertension) Market Competition by Company
2.1 Global Top Players by High Blood Pressure Drugs (Hypertension) Sales (2018-2023)
2.2 Global Top Players by High Blood Pressure Drugs (Hypertension) Revenue (2018-2023)
2.3 Global Top Players by High Blood Pressure Drugs (Hypertension) Price (2018-2023)
2.4 Global Top Manufacturers High Blood Pressure Drugs (Hypertension) Manufacturing Base Distribution, Sales Area, Product Type
2.5 High Blood Pressure Drugs (Hypertension) Market Competitive Situation and Trends
2.5.1 High Blood Pressure Drugs (Hypertension) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by High Blood Pressure Drugs (Hypertension) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in High Blood Pressure Drugs (Hypertension) as of 2022)
2.7 Date of Key Manufacturers Enter into High Blood Pressure Drugs (Hypertension) Market
2.8 Key Manufacturers High Blood Pressure Drugs (Hypertension) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 High Blood Pressure Drugs (Hypertension) Status and Outlook by Region
3.1 Global High Blood Pressure Drugs (Hypertension) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global High Blood Pressure Drugs (Hypertension) Historic Market Size by Region
3.2.1 Global High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2018-2023)
3.2.2 Global High Blood Pressure Drugs (Hypertension) Sales in Value by Region (2018-2023)
3.2.3 Global High Blood Pressure Drugs (Hypertension) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Region
3.3.1 Global High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2024-2029)
3.3.2 Global High Blood Pressure Drugs (Hypertension) Sales in Value by Region (2024-2029)
3.3.3 Global High Blood Pressure Drugs (Hypertension) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global High Blood Pressure Drugs (Hypertension) by Application
4.1 High Blood Pressure Drugs (Hypertension) Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global High Blood Pressure Drugs (Hypertension) Market Size by Application
4.2.1 Global High Blood Pressure Drugs (Hypertension) Market Size Overview by Application (2018-2029)
4.2.2 Global High Blood Pressure Drugs (Hypertension) Historic Market Size Review by Application (2018-2023)
4.2.3 Global High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America High Blood Pressure Drugs (Hypertension) Sales Breakdown by Application (2018-2023)
4.3.2 Europe High Blood Pressure Drugs (Hypertension) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America High Blood Pressure Drugs (Hypertension) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales Breakdown by Application (2018-2023)
5 North America High Blood Pressure Drugs (Hypertension) by Country
5.1 North America High Blood Pressure Drugs (Hypertension) Historic Market Size by Country
5.1.1 North America High Blood Pressure Drugs (Hypertension) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2018-2023)
5.1.3 North America High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2018-2023)
5.2 North America High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Country
5.2.1 North America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2024-2029)
5.2.2 North America High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2024-2029)
6 Europe High Blood Pressure Drugs (Hypertension) by Country
6.1 Europe High Blood Pressure Drugs (Hypertension) Historic Market Size by Country
6.1.1 Europe High Blood Pressure Drugs (Hypertension) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2018-2023)
6.1.3 Europe High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2018-2023)
6.2 Europe High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Country
6.2.1 Europe High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2024-2029)
6.2.2 Europe High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2024-2029)
7 Asia-Pacific High Blood Pressure Drugs (Hypertension) by Region
7.1 Asia-Pacific High Blood Pressure Drugs (Hypertension) Historic Market Size by Region
7.1.1 Asia-Pacific High Blood Pressure Drugs (Hypertension) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Region
7.2.1 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales in Value by Region (2024-2029)
8 Latin America High Blood Pressure Drugs (Hypertension) by Country
8.1 Latin America High Blood Pressure Drugs (Hypertension) Historic Market Size by Country
8.1.1 Latin America High Blood Pressure Drugs (Hypertension) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2018-2023)
8.1.3 Latin America High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2018-2023)
8.2 Latin America High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Country
8.2.1 Latin America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2024-2029)
8.2.2 Latin America High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2024-2029)
9 Middle East and Africa High Blood Pressure Drugs (Hypertension) by Country
9.1 Middle East and Africa High Blood Pressure Drugs (Hypertension) Historic Market Size by Country
9.1.1 Middle East and Africa High Blood Pressure Drugs (Hypertension) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa High Blood Pressure Drugs (Hypertension) Forecasted Market Size by Country
9.2.1 Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Introduction and Business Overview
10.1.3 Eli Lilly High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eli Lilly High Blood Pressure Drugs (Hypertension) Products Offered
10.1.5 Eli Lilly Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer High Blood Pressure Drugs (Hypertension) Products Offered
10.2.5 Pfizer Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bayer High Blood Pressure Drugs (Hypertension) Products Offered
10.3.5 Bayer Recent Development
10.4 Symplmed
10.4.1 Symplmed Company Information
10.4.2 Symplmed Introduction and Business Overview
10.4.3 Symplmed High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Symplmed High Blood Pressure Drugs (Hypertension) Products Offered
10.4.5 Symplmed Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis High Blood Pressure Drugs (Hypertension) Products Offered
10.5.5 Novartis Recent Development
10.6 Merck
10.6.1 Merck Company Information
10.6.2 Merck Introduction and Business Overview
10.6.3 Merck High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Merck High Blood Pressure Drugs (Hypertension) Products Offered
10.6.5 Merck Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanofi High Blood Pressure Drugs (Hypertension) Products Offered
10.7.5 Sanofi Recent Development
10.8 Boryung
10.8.1 Boryung Company Information
10.8.2 Boryung Introduction and Business Overview
10.8.3 Boryung High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Boryung High Blood Pressure Drugs (Hypertension) Products Offered
10.8.5 Boryung Recent Development
10.9 Reata Pharmaceuticals
10.9.1 Reata Pharmaceuticals Company Information
10.9.2 Reata Pharmaceuticals Introduction and Business Overview
10.9.3 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Products Offered
10.9.5 Reata Pharmaceuticals Recent Development
10.10 Lung Biotechnology
10.10.1 Lung Biotechnology Company Information
10.10.2 Lung Biotechnology Introduction and Business Overview
10.10.3 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Products Offered
10.10.5 Lung Biotechnology Recent Development
10.11 Yuhan
10.11.1 Yuhan Company Information
10.11.2 Yuhan Introduction and Business Overview
10.11.3 Yuhan High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Yuhan High Blood Pressure Drugs (Hypertension) Products Offered
10.11.5 Yuhan Recent Development
10.12 Takeda
10.12.1 Takeda Company Information
10.12.2 Takeda Introduction and Business Overview
10.12.3 Takeda High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Takeda High Blood Pressure Drugs (Hypertension) Products Offered
10.12.5 Takeda Recent Development
10.13 Alvogen
10.13.1 Alvogen Company Information
10.13.2 Alvogen Introduction and Business Overview
10.13.3 Alvogen High Blood Pressure Drugs (Hypertension) Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Alvogen High Blood Pressure Drugs (Hypertension) Products Offered
10.13.5 Alvogen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 High Blood Pressure Drugs (Hypertension) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 High Blood Pressure Drugs (Hypertension) Industrial Chain Analysis
11.4 High Blood Pressure Drugs (Hypertension) Market Dynamics
11.4.1 High Blood Pressure Drugs (Hypertension) Industry Trends
11.4.2 High Blood Pressure Drugs (Hypertension) Market Drivers
11.4.3 High Blood Pressure Drugs (Hypertension) Market Challenges
11.4.4 High Blood Pressure Drugs (Hypertension) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 High Blood Pressure Drugs (Hypertension) Distributors
12.3 High Blood Pressure Drugs (Hypertension) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’